Macrophage- or neutrophil-expressed UPP1 drives tumor growth and immune suppression in the tumor microenvironment
- 16 October 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (42)
Abstract
Uridine phosphorylase 1 (UPP1) has recently emerged as a metabolic regulator with critical roles in tumor cell biology. However, its expression pattern and functional significance in nonmalignant components of the tumor microenvironment (TME) remain largely unexplored. Here, we performed a comprehensive pan-cancer single-cell transcriptomic analysis revealing that UPP1 is highly expressed not only in tumor cells but also in tumor-associated macrophages (TAMs) and neutrophils (TANs). Clinically, UPP1 expression in TAMs and TANs correlates with poor prognosis and diminished response to immunotherapy across multiple cancer types. Mechanistically, UPP1 up-regulation could be driven by NF-κB signaling. Functionally, UPP1 reprograms macrophages toward a tumor-promoting phenotype, characterized by enhanced glycolysis, ATP-adenosine signaling activation, and increased production of immunosuppressive cytokines such as granulocyte colony-stimulating factor. In neutrophils, UPP1 also supports TAN polarization, influences neutrophil extracellular trap release, and contributes to broad immunosuppressive remodeling. In vivo, targeting UPP1 in macrophages or neutrophils reprograms the immune landscape and restrains tumor progression. Together, our findings uncover a previously underappreciated role of UPP1 in nonmalignant immune populations and establish it as a key immune mediator within the TME, offering a potentially promising therapeutic target for enhancing antitumor immunity.Keywords
Funding Information
- National Natural Science Foundation of China (823B2070)
- National Natural Science Foundation of China (82573009)
- The Third People's Hospital of Chengdu Clinical Research Program (CSY-YN-01-2023-002)
- the PI Program of the Third People’s Hospital of Chengdu (2023PI01)
- the Zhongshan Hospital “Excellent Resident Physician” Clinical Postdoctoral Fellowship Program
- The Zhongshan Hospital Resident Training Special Fund (ZSZP202523)
This publication has 71 references indexed in Scilit:
- Tumor-associated neutrophils and neutrophil-targeted cancer therapiesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancerCancer Cell, 2021
- Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancerCancer Cell, 2021
- Conserved pan-cancer microenvironment subtypes predict response to immunotherapyCancer Cell, 2021
- Uridine phosphorylase 1 is a novel immune‐related target and predicts worse survival in brain gliomaCancer Medicine, 2020
- CCR9 and CCL25: A review of their roles in tumor promotionJournal of Cellular Physiology, 2020
- An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic CandidatesCancer Cell, 2020
- Directional Collective Migration in Wound Healing Assays2018
- The pivotal role of uridine-cytidine kinases in pyrimidine metabolism and activation of cytotoxic nucleoside analogues in neuroblastomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
- Adenosine acts as a chemoprotective agent by stimulating G-CSF production: A role for A1 and A3 adenosine receptorsJournal of Cellular Physiology, 2000